Project R-15869

Title

Translation of therapeutic insight into innovative intervention in MS (Research)

Abstract

In this project the in vitro and in vivo data package for a newly identified drug target for multiple sclerosis will be evaluated, resulting in a SWOT analysis. When the SWOT analysis warrants continuation of the project, a specific drug screening and development plan will be generated.

Period of project

16 June 2025 - 15 June 2026